高级搜索
判断乳腺癌预后相关检测的研究[J]. 肿瘤防治研究, 2004, 31(07): 418-419. DOI: 10.3971/j.issn.1000-8578.266
引用本文: 判断乳腺癌预后相关检测的研究[J]. 肿瘤防治研究, 2004, 31(07): 418-419. DOI: 10.3971/j.issn.1000-8578.266
Study of Prognestic Interrelate Examination in Breast Invasive Duct Carcinoma[J]. Cancer Research on Prevention and Treatment, 2004, 31(07): 418-419. DOI: 10.3971/j.issn.1000-8578.266
Citation: Study of Prognestic Interrelate Examination in Breast Invasive Duct Carcinoma[J]. Cancer Research on Prevention and Treatment, 2004, 31(07): 418-419. DOI: 10.3971/j.issn.1000-8578.266

判断乳腺癌预后相关检测的研究

Study of Prognestic Interrelate Examination in Breast Invasive Duct Carcinoma

  • 摘要: 目的 探讨 97例乳腺浸润性导管癌的MVD、VEGF、CD和抑癌基因 p5 3的表达特征, 判断其转移和生存时间的关系及临床应用意义。方法 应用免疫组化S P法和计算机图文分析处理系统, 分析处理不同标记物的表达特征。结果  97例乳腺浸润性导管癌中, 小于 5年组的MVD均值为 6 6 .0 5±2 3.86, 大于 5年组的MVD均值为 5 4 .0 0± 2 3.4 7。小于 5年组中VEGF、CD、p5 3阳性表达及MVD均值高于大于 5年组, 其P值均 <0 .0 1,0 .0 5及 0 .0 0 0 5, 有显著性差异。结论  97例乳腺浸润导管癌中, 5年内发生转移和死亡组, 其VEGF、CD, p5 3阳性表达和MVD高于 5年以上发生转移和死亡组。

     

    Abstract: Objective To inquire the feature of MVD,VEGF,CD and p53 expression of 97 invasive duct breast carcinoma cases,and to judge the relation ship between metastasis and survival rate the significance of clinical practice. Methods Immunohistochemical S P method and ressls were count by computer assisted analysis. Results The value of MVD was 66.05 ± 23.86 in less than five year group (Group A), 54.00 ± 23.47 in more than five year group (Group B). Group A,VEGF,CD,p53 positive expression and MV...

     

/

返回文章
返回